Jeena Sikho Lifecare buys 51% stake in UAE ayurveda provider

Jeena Sikho Lifecare board members approved the acquisition of a 51% controlling interest in an unnamed UAE-based ayurvedic firm on January 16, 2026. This transaction marks the company’s first entry into the Gulf market, shifting its operational scope from domestic Indian clinics to international expansion.

The Dubai Health Authority and the Department of Health – Abu Dhabi oversee the licensing of these facilities. Their current regulations require all ayurvedic practitioners to hold professional licenses that meet clinical standards consistent with conventional healthcare mandates. Investors should monitor how these mandates affect operational costs as firms integrate new clinics.

This 51% stake allows Jeena Sikho Lifecare to consolidate financial results under Indian accounting standards. Competitors in the UAE wellness sector now face pressure to differentiate service models against companies with established proprietary supply chains. Firms expanding in the UAE must also comply with the Ministry of Health and Prevention advertising guidelines, which mandate that all promotional materials undergo review to prevent unsubstantiated health claims.

Facility operators must integrate electronic medical records to meet requirements under the UAE’s Unified Health Record initiative. Licensing transfer costs represent the primary barrier to entry for smaller healthcare providers looking to replicate this expansion strategy.